STOCK TITAN

Semnur Pharmaceuticals Stock Price, News & Analysis

SMNR OTC Link

Company Description

Semnur Pharmaceuticals (OTC Link: SMNR) is a publicly traded company.

SMNR stock has declined 60.0% over the past year. Shares last traded at $8.00.

On a trailing twelve-month basis, Semnur Pharmaceuticals reported net income of -$160.4M and diluted earnings per share of $-0.78.

This page provides a comprehensive overview of SMNR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-60%
Performance 1 year

Semnur Pharmaceuticals (SMNR) stock last traded at $8.00. Over the past 12 months, the stock has lost 60.0%.

Latest News

No recent news available for SMNR.

SEC Filings

Semnur Pharmaceuticals has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 10-K, 1 Form S-1/A, 1 Form 10-Q. The most recent filing was submitted on March 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SMNR SEC filings →

Financial Highlights

-$160.4M
Net Income (TTM)
-$5.9M
Operating Cash Flow
Revenue (TTM)

operating income reached -$160.4M, and net income was -$160.4M. Diluted earnings per share stood at $-0.78. The company generated -$5.9M in operating cash flow. With a current ratio of 0.06, short-term liquidity bears monitoring.

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Semnur Pharmaceuticals (SMNR) currently stands at 1.5 thousand shares, down 6.3% from the previous reporting period, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. The 6.6 days to cover indicates moderate liquidity for short covering.

Days to Cover History

Last 12 Months

Days to cover for Semnur Pharmaceuticals (SMNR) currently stands at 6.6 days, down 60.5% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has decreased 33.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 6.6 to 1000.0 days.

Frequently Asked Questions

What is the current stock price of Semnur Pharmaceuticals (SMNR)?

The current stock price of Semnur Pharmaceuticals (SMNR) is $8 as of February 23, 2026.

What is the net income of Semnur Pharmaceuticals (SMNR)?

The trailing twelve months (TTM) net income of Semnur Pharmaceuticals (SMNR) is -$160.4M.

What is the earnings per share (EPS) of Semnur Pharmaceuticals (SMNR)?

The diluted earnings per share (EPS) of Semnur Pharmaceuticals (SMNR) is $-0.78 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Semnur Pharmaceuticals (SMNR)?

The operating cash flow of Semnur Pharmaceuticals (SMNR) is -$5.9M. Learn about cash flow.

What is the current ratio of Semnur Pharmaceuticals (SMNR)?

The current ratio of Semnur Pharmaceuticals (SMNR) is 0.06, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Semnur Pharmaceuticals (SMNR)?

The operating income of Semnur Pharmaceuticals (SMNR) is -$160.4M. Learn about operating income.